397 related articles for article (PubMed ID: 38646648)
1. Theranostics - a sure cure for cancer after 100 years?
Song Y; Zou J; Castellanos EA; Matsuura N; Ronald JA; Shuhendler A; Weber WA; Gilad AA; Müller C; Witney TH; Chen X
Theranostics; 2024; 14(6):2464-2488. PubMed ID: 38646648
[TBL] [Abstract][Full Text] [Related]
2. Versatile Nanosystem-Based Cancer Theranostics: Design Inspiration and Predetermined Routing.
Opoku-Damoah Y; Wang R; Zhou J; Ding Y
Theranostics; 2016; 6(7):986-1003. PubMed ID: 27217832
[TBL] [Abstract][Full Text] [Related]
3. Radiotheranostics in Cancer Diagnosis and Management.
Jadvar H; Chen X; Cai W; Mahmood U
Radiology; 2018 Feb; 286(2):388-400. PubMed ID: 29356634
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
[TBL] [Abstract][Full Text] [Related]
5. Theranostics and metabolotheranostics for precision medicine in oncology.
Bhujwalla ZM; Kakkad S; Chen Z; Jin J; Hapuarachchige S; Artemov D; Penet MF
J Magn Reson; 2018 Jun; 291():141-151. PubMed ID: 29705040
[TBL] [Abstract][Full Text] [Related]
6. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
Ma Y; Huang J; Song S; Chen H; Zhang Z
Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
[TBL] [Abstract][Full Text] [Related]
7. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
[TBL] [Abstract][Full Text] [Related]
8. Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy.
Jo SD; Ku SH; Won YY; Kim SH; Kwon IC
Theranostics; 2016; 6(9):1362-77. PubMed ID: 27375785
[TBL] [Abstract][Full Text] [Related]
9. Magnetic mediators for ultrasound theranostics.
Józefczak A; Kaczmarek K; Bielas R
Theranostics; 2021; 11(20):10091-10113. PubMed ID: 34815806
[TBL] [Abstract][Full Text] [Related]
10. Radiotheranostics - Precision Medicine in Nuclear Medicine and Molecular Imaging.
Duan H; Iagaru A; Aparici CM
Nanotheranostics; 2022; 6(1):103-117. PubMed ID: 34976584
[TBL] [Abstract][Full Text] [Related]
11. Theranostics of metal-organic frameworks: image-guided nanomedicine for clinical translation.
Mehata AK; Vikas ; Viswanadh MK; Muthu MS
Nanomedicine (Lond); 2023 Apr; 18(8):695-703. PubMed ID: 37259854
[TBL] [Abstract][Full Text] [Related]
12. Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases.
Patel SK; Janjic JM
Theranostics; 2015; 5(2):150-72. PubMed ID: 25553105
[TBL] [Abstract][Full Text] [Related]
13. Supramolecular cancer nanotheranostics.
Zhou J; Rao L; Yu G; Cook TR; Chen X; Huang F
Chem Soc Rev; 2021 Feb; 50(4):2839-2891. PubMed ID: 33524093
[TBL] [Abstract][Full Text] [Related]
14. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
Cai Y; Chen X; Si J; Mou X; Dong X
Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
[TBL] [Abstract][Full Text] [Related]
15. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
16. Theranostics and artificial intelligence: new frontiers in personalized medicine.
Belge Bilgin G; Bilgin C; Burkett BJ; Orme JJ; Childs DS; Thorpe MP; Halfdanarson TR; Johnson GB; Kendi AT; Sartor O
Theranostics; 2024; 14(6):2367-2378. PubMed ID: 38646652
[TBL] [Abstract][Full Text] [Related]
17. Current Trends in Nanotheranostics: A Concise Review on Bioimaging and Smart Wearable Technology.
Sharma AK
Nanotheranostics; 2023; 7(3):258-269. PubMed ID: 37064611
[TBL] [Abstract][Full Text] [Related]
18. Magnetic Nanoparticles in Cancer Theranostics.
Gobbo OL; Sjaastad K; Radomski MW; Volkov Y; Prina-Mello A
Theranostics; 2015; 5(11):1249-63. PubMed ID: 26379790
[TBL] [Abstract][Full Text] [Related]
19. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
Kundu P; Singh D; Singh A; Sahoo SK
Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
[TBL] [Abstract][Full Text] [Related]
20. Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cells.
Kojima R; Aubel D; Fussenegger M
Curr Opin Chem Biol; 2015 Oct; 28():29-38. PubMed ID: 26056952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
